Director, US Market Access Pipeline, Immunology

Director, USMAx Pipeline leads US market access strategy development for early pipeline priority assets within Immunology, ensuring payer needs and the U.S. health system are integrated into early asset development and governance. The role serves as the voice of U.S. payers in early drug development and represents USMAx in pipeline governance and cross-functional discussions. The position collaborates across the AbbVie Pipeline Commercialization Model to shape integrated asset strategies and value propositions for the portfolio.